• SENSEX 81,451.01
    -182.01 (--0.22%)
  • BANKNIFTY 55,749.70
    203.65 (+0.37%)
  • Suzlon Energy
    74.30 86.04(%)
  • Reliance Power
    60.50 60.50(%)
  • Swiggy
    338.00 617.00(%)
  • Mazagon Dock
    3,450.00 1,200.00(%)
  • Eternal Ltd
    243.00 304.50(%)
  • MMTC
    88.20 131.88(%)
  • Garden Reach Sh.
    2,926.85 1,148.10(%)
  • Waaree Energies
    2,956.60 1,808.65(%)
  • Indian Energy Ex
    203.20 244.35(%)
  • Bharat Dynamics
    2,096.00 2,096.00(%)
  • Engineers India
    239.00 304.00(%)
  • NBCC
    126.41 139.83(%)
  • IFCI
    66.71 35.67(%)
  • Muthoot Finance
    2,241.75 2,444.65(%)
  • HDFC Bank
    1,948.60 1,977.95(%)
  • LMW
    16,640.85 13,456.85(%)
  • Hind.Aeronautics
    4,962.00 3,045.95(%)
  • Pidilite Inds.
    3,127.25 3,414.40(%)
  • Infosys
    1,555.10 1,307.10(%)
  • Ola Electric
    48.07 45.55(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Neuland Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 3800.0
  • ISIN : INE794A01010
11,503.00 273 (2.43%)
  • As on 01 Jun 2025 (EOD)

  • Today’s Low

    11,255.00

  • Today’s High

    11,556.00

  • Open

    11,255.00

  • Perv Close

    11,230.00

  • 52W Low

    5,540.10

  • 52W High

    18,100.00

Key Indicators

  • P/E(TTM)

    73.04

  • Mar.Cap (₹Cr.)

    14,758.22

  • Div & Yield %

    0.10

  • Book Value(₹)

    1,182.30

  • Debt-Equity Ratio

    2.43

  • AGM Date

    30-May-2025

  • EPS

    157.47

  • P/E Ratio

    73.04

Financials Ratios

  • Debt-Equity Ratio

    0.10

  • Mar.Cap (₹Cr.)

    14,758.22

  • RONW (%)

    26.38

  • ROCE (%)

    33.01

Score Board

  • Equity (₹ in Cr.)

    12.83

  • BV (₹)

    1,182.30

  • Sales( ₹ in Cr.)

    1,476.84

  • NP (in Cr.)

    202.04

  • NP Var(%)

    -33.0

  • Div%

    120.0

  • CPS (₹)

    208.60

  • EPS (₹)

    157.50

  • Traded Value (₹ in Lakhs)

    14,757.00

  • 52 Week High

    18,100.00

  • 52 Week Low

    5,540.10

  • Price BSE

    11502.0

  • Price NSE

    11,503.00

  • Market Capital( in Cr.)

    14,757.00

  • P/C Ratio

    55.20

  • P/E Ratio

    73.00

  • Price Vs.BV

    157.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 1,558.58 1,191.20 951.08 936.91 762.71 666.83
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,558.58 1,191.20 951.08 936.91 762.71 666.83
Other Income 12.54 9.75 2.08 16.09 3.89 3.49
Stock Adjustments 55.14 9.51 15.41 1.24 11.16 -5.80
Total Income 1,626.26 1,210.46 968.57 954.24 777.76 664.52
EXPENDITURE :            
Raw Materials 636.49 491.98 441.79 443.04 394.41 363.03
Power and Fuel Cost 48.72 48.62 42.21 39.21 32.75 26.81
Employee Cost 248.53 194.84 175.76 144.02 118.48 104.47
Other Manufacturing Expenses 103.73 82.69 84.92 73.71 61.79 47.51
Selling and Administration Expenses 104.29 88.50 70.50 79.80 51.76 52.57
Miscellaneous Expenses 10.04 22.77 9.12 11.93 13.21 8.76
Employee Benefit Expenses 248.53 194.84 175.76 144.02 118.48 104.47
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,151.81 929.40 824.29 791.71 672.41 603.16
Operating Profit 474.47 281.06 144.27 162.54 105.34 61.36
Interest 14.00 13.07 13.49 17.90 21.57 15.66
Gross Profit 460.47 267.99 130.78 144.64 83.77 45.70
Depreciation 59.70 52.78 49.04 39.68 31.28 25.86
Profit Before Tax 400.77 215.21 81.74 104.96 52.49 19.84
Current Tax 99.59 50.39 20.42 12.48 0.00 5.44
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 1.59 1.70 -2.22 12.18 36.62 -1.75
Reported Net Profit 299.60 163.12 63.53 80.29 15.88 16.14
Extraordinary Items -0.30 -0.66 -1.36 9.81 0.12 -0.09
Adjusted Net Profit 299.90 163.78 64.89 70.48 15.76 16.23
Adjustment below Net Profit 0.00 0.00 0.00 0.00 -0.18 0.00
P & L Balance brought forward 460.54 303.84 244.15 166.42 155.67 139.53
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 12.83 6.41 3.85 2.57 4.95 0.00
P & L Balance carried down 747.31 460.54 303.84 244.15 166.42 155.67
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 140.00 100.00 50.00 50.00 20.00 0.00
Dividend Per Share(Rs) 14.00 10.00 5.00 5.00 2.00 0.00
Earnings Per Share-Unit Curr 232.24 126.44 49.25 62.24 12.31 12.51
Earnings Per Share(Adj)-Unit Curr 232.24 126.44 49.25 62.24 12.31 12.51
Book Value 988.88 765.49 647.06 605.44 546.26 538.54
Book Value(Adj)-Unit Curr 988.88 765.49 647.06 605.44 546.26 538.54

Shareholding Pattern

  • Promoter Group

    32.68%

  • Public Share Holding

    67.32%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 200 200.00 200 200
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 200 0.00 200 2
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 858,632 6.69 858,632 9
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 3,333,352 25.98 3,333,352 1
Others 0 0.00 0 0
Sub Total 4,191,984 32.67 4,191,984 10
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 51,304 0.40 51,304 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 2,837,026 22.11 2,837,026 189
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 122,983 0.96 122,983 3
Mutual Funds / UTI 953,428 7.43 953,428 23
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 330,772 2.58 330,772 34
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 4,295,513 33.48 4,295,513 250
2] Non Institution
Bodies Corporate 699,053 5.45 698,253 682
Clearing Members 6,574 0.05 6,574 5
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 164,312 1.28 151,812 1,102
Foreign Non Institution Other 100 0.00 0 1
Hindu Undivided Families 86,854 0.68 85,454 849
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 916,137 7.14 916,137 10
Individuals holding nominal share capital up to Rs. 1 lakh 2,401,259 18.72 2,352,740 36,409
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 23,045 0.18 23,045 12
Others 44,858 0.35 44,858 1
Sub Total 4,342,192 33.84 4,278,873 39,071
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 12,829,889 100.00 12,766,570 39,333

Company Background

Neuland Laboratories LtdPharmaceuticals - Indian - Bulk Drugs

  • Neuland Laboratories Ltd
  • BSE Code : 3800.0
  • ISIN : INE794A01010

  • Incorporation Year

    1984

  • Registered Office

    11 Th Floor Phoenix IVY Buildi
    Plot No 573A-III Road No 82, Hyderabad,
    Telangana-500035

  • Telephone

    91-40-30211600

  • FAX

    91-40-30211602

  • Chairman

    D Saharsh Rao

  • Managing Director

  • Company Secretary

    Sarada Bhamidipati

  • Auditor

    MSKA & Associates

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Neuland Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Neuland Labs. 11,502.05 1,571.12 1,558.58 56.88 33.13
Abbott India 30,453.15 6,097.18 5,848.91 45.75 44.71
Astrazeneca Phar 7,965.20 1,330.33 1,295.53 205.34 33.26
P & G Health Ltd 5,775.85 1,166.89 1,151.26 40.53 39.76
Glaxosmi. Pharma 3,295.00 3,530.73 3,407.25 60.74 44.44
Cipla 1,464.85 17,645.00 16,574.34 22.94 20.10
Amrutanjan Healt 711.95 437.58 421.23 40.50 20.84
Fermenta Biotec. 311.95 315.24 307.09 13.58 4.10
Guj. Themis Bio. 307.95 174.19 169.82 68.74 44.82
Bliss GVS Pharma 131.10 638.96 605.46 20.02 11.19
Ambalal Sarabhai 37.87 11.70 3.81 16.18 1.92